Hyperion DeFi (NASDAQ:HYPD) Cut to “Strong Sell” at Zacks Research

Zacks Research cut shares of Hyperion DeFi (NASDAQ:HYPD) from a hold rating to a strong sell rating in a research report sent to investors on Monday morning,Zacks.com reports.

Several other brokerages also recently weighed in on HYPD. Cantor Fitzgerald assumed coverage on Hyperion DeFi in a report on Tuesday, December 16th. They set an “overweight” rating and a $4.00 price target for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperion DeFi in a research note on Thursday, January 22nd. Finally, Chardan Capital set a $7.75 price objective on shares of Hyperion DeFi and gave the stock a “buy” rating in a research report on Wednesday, December 24th. Two analysts have rated the stock with a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.88.

Hyperion DeFi Stock Performance

Shares of HYPD stock opened at $3.27 on Monday. The stock’s 50-day moving average price is $3.49 and its 200 day moving average price is $5.08. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $26.72 million, a PE ratio of -0.28 and a beta of 2.62. Hyperion DeFi has a 52-week low of $0.85 and a 52-week high of $17.18.

Hyperion DeFi (NASDAQ:HYPD) last posted its quarterly earnings data on Thursday, March 26th. The company reported ($7.76) earnings per share for the quarter. The business had revenue of $0.50 million during the quarter. As a group, equities research analysts forecast that Hyperion DeFi will post -41.6 EPS for the current year.

Institutional Trading of Hyperion DeFi

Several hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD acquired a new position in Hyperion DeFi during the fourth quarter worth $73,000. State Street Corp acquired a new stake in Hyperion DeFi in the fourth quarter valued at $92,000. Jane Street Group LLC purchased a new stake in shares of Hyperion DeFi during the 4th quarter worth $493,000. Renaissance Technologies LLC purchased a new stake in shares of Hyperion DeFi during the 4th quarter worth $663,000. Finally, Focus Partners Advisor Solutions LLC acquired a new position in shares of Hyperion DeFi during the 4th quarter worth $221,000. 25.84% of the stock is owned by institutional investors and hedge funds.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.